One of Hollywood’s longest lasting couples, Hugh Jackman, 54, and Deborra-Lee Jackman, 67, shocked audiences when they shared the news that they are going their separate ways. The duo, who share 2 children, have been together for half their lives and the reason for their soon-to-come divorce has been revealed, and it’s nothing like what people expected.
Hugh and Deborra-Lee met in 1995.
Hugh Jackman and Deborra-Lee Furness met on the set of the Australian TV series Correlli in 1995, on the first day of the actor’s first job after drama school.
“She was a big star. Everyone loved Deb. I get picked up by the car and Deb is in the front seat of the car. I get in the backseat. She had sunglasses on, she took off her seatbelt, turned around and said ‘Hi, I’m Deborra-Lee Furness, nice to meet you.’ and I remember thinking, ‘I like this girl’.”
6 weeks into filming, Jackman noticed a man courting Deborra-Lee, and he thought “that man has a crush on her”. That’s when he realized he was actually jealous of the man, and he had a crush on her himself. A few days later, after not talking to her for one week, he confessed his feelings and to his surprise, she reciprocated; she told him she was also crushing on him and that’s how their love story began.
After 11 months of dating, Hugh and Deborra-Lee tied the knot.
Over the following years, the couple struggled with infertility and experienced many failed IVF attempts and sadly, multiple miscarriages, all of which were “particularly difficult on Deb,” Jackman shared. Becoming parents was always their plan, Jackman shared, “We thought we’d have a kid or two biologically and then adopt. But when we decided we’d had enough of IVF, we went ahead with adoption.”
In 2000, they adopted their eldest son, Oscar, now 23 years old, and their daughter Ava, in 2005, who recently turned 18.
Hugh Jackman and Deborra-Lee had a happy life together.
The two never missed a moment to show each other and the world how much they mean to each other. Every single year Jackman honored his wife by publicly sharing how much he loves her and fans always admired and gushed over the outpour of love.
In April 2023, on their 27th and last wedding anniversary, Jackman shared a loving tribute to his wife, stating, “27 YEARS! I love you so much, and together we have created a beautiful family. And life. Your laughter, your spirit, generosity, humor, cheekiness, courage, loyalty is an incredible gift to me. I love you with all my heart.”
Just a few months later, one of Hollywood’s most loved duos announced their separation.
In a joint statement, Hugh Jackman and Deborra-Lee announced, “We have been blessed to share almost 3 decades together as husband and wife in a wonderful, loving marriage. Our journey now is shifting, and we have decided to separate to pursue our individual growth.
Our family has been and always will be our highest priority. We undertake this next chapter with gratitude, love, and kindness. We greatly appreciate your understanding in respecting our privacy as our family navigates this transition in all of our lives.”
2023 brought many Hollywood couples to a stop, with many celebrities divorcing after years spent together. Another recent divorce was Joe Jonas and Sophie Turner’s and their reason, although different than the ex-Jackmans’, is equally devastating.
A new cancer vaccine trains the immune system to recognize and attack tumor cells
The fight against cancer has taken a revolutionary step forward with the development of a new cancer vaccine designed to train the immune system to recognize and attack tumor cells. This breakthrough could change the way cancer is treated, offering a safer and more effective alternative to traditional therapies like chemotherapy and radiation.
Researchers have been working tirelessly to create a vaccine that not only targets cancer cells but also prevents the disease from recurring. Now, early trials are showing promising results, giving hope to millions of patients worldwide.
But how does this cancer vaccine work, and what makes it so different from existing treatments? Let’s explore the science behind this potential game-changer in cancer therapy.
How the Cancer Vaccine Works
Unlike traditional vaccines that prevent diseases like the flu or measles, this cancer vaccine is a therapeutic vaccine—meaning it is designed to help the body fight cancer that is already present.
Training the Immune System to Fight Cancer
The vaccine works by educating the immune system to recognize tumor-specific antigens—proteins found on the surface of cancer cells that distinguish them from healthy cells.
Here’s how it works:
- Identifying the Enemy – The vaccine is formulated using specific tumor antigens or modified messenger RNA (mRNA) to signal the immune system.
- Activating the Immune Response – Once injected, the vaccine stimulates the body to produce T cells (immune cells) that recognize and attack cancerous cells.
- Targeting Tumor Cells – These trained immune cells then circulate throughout the body, seeking out and destroying cancer cells wherever they appear.
- Long-Term Protection – Unlike chemotherapy, which only works while it’s being administered, the vaccine helps the immune system remember the cancer, reducing the chances of recurrence.
Video : ArtScience Talks @ Le Lab – Seeing Is Believing: Therapeutic Cancer Vaccines
What Makes This Cancer Vaccine Different?
This innovative approach is drastically different from traditional cancer treatments in several ways:
1. It Targets Cancer Cells Without Harming Healthy Tissue
Chemotherapy and radiation damage both cancer cells and healthy cells, leading to severe side effects like hair loss, nausea, and fatigue. The cancer vaccine, however, trains the immune system to attack only tumor cells, minimizing harm to healthy tissues.
2. It Reduces the Risk of Recurrence
One of the biggest challenges with cancer is its ability to return even after successful treatment. This vaccine helps the immune system “remember” cancer cells, making it more likely to prevent relapse.
3. It Works for Multiple Types of Cancer
Researchers are developing versions of the vaccine to target a variety of cancers, including:
- Lung cancer
- Breast cancer
- Pancreatic cancer
- Melanoma (skin cancer)
- Brain tumors
While each type of cancer has unique characteristics, the vaccine can be customized to match the specific tumor antigens of different cancers.
4. It’s Less Invasive Than Other Treatments
Traditional treatments like surgery, radiation, and chemotherapy require intensive procedures that take a toll on the body. The cancer vaccine is administered via injection, making it less invasive and easier to tolerate.
Early Clinical Trials Show Encouraging Results
What Have Scientists Discovered So Far?
Recent clinical trials have demonstrated promising outcomes, particularly in patients with aggressive and advanced-stage cancers.
- In a study led by BioNTech (the company behind the Pfizer COVID-19 vaccine), an mRNA-based cancer vaccine triggered a strong immune response in patients with pancreatic cancer.
- Another trial conducted at Harvard Medical School showed that the vaccine helped shrink tumors in patients with melanoma and prevented cancer from spreading.
- Preliminary data suggest that patients receiving the vaccine alongside immunotherapy drugs experience better survival rates compared to those receiving standard treatment alone.
While these results are early-stage, they provide hope that a widely available cancer vaccine could become a reality within the next few years.
Challenges and Future of Cancer Vaccination
Overcoming the Challenges
Despite the exciting progress, researchers still face challenges in making the vaccine widely available and effective for all patients.
- Personalized Treatment Approach – Since cancer varies from person to person, researchers are working on ways to tailor the vaccine to individual patients based on their genetic makeup.
- Scaling Up Production – Manufacturing these vaccines at a global scale while ensuring affordability remains a challenge.
- Regulatory Approval – The vaccine must go through rigorous testing and approval processes before becoming a standard treatment.
Video : Personalized cancer vaccines may train the body’s immune system to fight tumors
The Future of Cancer Vaccination
If successful, cancer vaccines could become a routine part of cancer treatment and prevention. Experts predict that within the next 5 to 10 years, we may see cancer vaccines used in combination with immunotherapy and other targeted treatments.
How This Could Change Cancer Treatment Forever
A world where cancer can be treated with a simple vaccine might not be as far away as we once thought. If this vaccine continues to show positive results in clinical trials, it could:
Reduce dependence on chemotherapy and radiation
Provide long-term immunity against cancer recurrence
Offer a more affordable, accessible cancer treatment option
Improve survival rates and quality of life for patients
Imagine a future where getting a cancer vaccine is as routine as getting a flu shot—a future where cancer is no longer a deadly disease but a manageable condition.
Final Thoughts: A New Era in Cancer Treatment
The development of a cancer vaccine that trains the immune system to fight tumor cells is one of the most exciting medical breakthroughs in recent history.
While more research is needed, the early findings suggest that this revolutionary approach could one day transform cancer treatment, making it more effective, less toxic, and more widely available.
What do you think about this potential game-changing cancer vaccine? Could it be the next big step in medical science? Share your thoughts in the comments below!
Leave a Reply